Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

GENE:

FLT4 (Fms-related tyrosine kinase 4)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related tests:

‹

AVENIO Tumor Tissue Expanded Kit

AVENIO ctDNA Expanded Kit

Archer™ VARIANTPlex™ Pan Solid Tumor panel

AVENIO Tumor Tissue Expanded Kit

AVENIO ctDNA Expanded Kit

Archer™ VARIANTPlex™ Pan Solid Tumor panel

›

FLT4 T494A	Neuroendocrine Tumor	FLT4 T494A	Neuroendocrine Tumor	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3
FLT4 R1324L	Neuroendocrine Tumor	FLT4 R1324L	Neuroendocrine Tumor	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3	pazopanib Resistant: C3 – Early Trials pazopanib Resistant : C3
KDR amplification + FLT4 amplification + MCL1 amplification + TP53 R213 + TP53 H179Y + ARID1A Q2128	Sarcoma	KDR amplification + FLT4 amplification + MCL1 amplification + TP53 R213 + TP53 H179Y + ARID1A Q2128	Sarcoma	sorafenib Resistant: C4 – Case Studies sorafenib Resistant : C4	sorafenib Resistant: C4 – Case Studies sorafenib Resistant : C4
FLT4 amplification	Sarcoma	FLT4 amplification	Sarcoma	pazopanib Sensitive: C4 – Case Studies pazopanib Sensitive : C4	pazopanib Sensitive: C4 – Case Studies pazopanib Sensitive : C4
FGFR3 amplification + FGFR4 amplification + FLT4 amplification	Ewing Sarcoma	FGFR3 amplification + FGFR4 amplification + FLT4 amplification	Ewing Sarcoma	trametinib + pazopanib Resistant: C4 – Case Studies trametinib + pazopanib Resistant : C4	trametinib + pazopanib Resistant: C4 – Case Studies trametinib + pazopanib Resistant : C4
FLT4 overexpression	Renal Cell Carcinoma	FLT4 overexpression	Renal Cell Carcinoma	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D